Literature DB >> 12926841

The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient.

Fabrizio G Mastronardi1, Luis A G daCruz, Huimin Wang, Joan Boggs, Mario A Moscarello.   

Abstract

We have demonstrated that sonic hedgehog (Shh), vital for oligodendrocyte development, is present in both gray and white matter of normal human brain. Both the 45 kDa precursor protein and the 20 kDa N-terminal sonic hedgehog signaling portion (ShhN) were demonstrated by immunoblot and a partial purification has been achieved. In gray matter from brains of multiple sclerosis (MS) victims, the total amount of Shh was less than normals and the signaling 20 kDa protein was greatly reduced. In white matter homogenates, prepared from MS victims, only the 45 kDa precursor protein was found. None of the 20 kDa signaling protein was detected, suggesting that the 45 kDa signaling protein was not cleaved in the autocatalytic reaction carried out by the C-terminal portion. The 45 kDa protein and a small amount of the 20 kDa ShhN was detected in isolated MS myelin by Western blot, demonstrating some cleavage was possible. The cleavage of the 45 kDa protein was demonstrated in normal myelin in vitro, but not in myelin prepared from MS brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926841     DOI: 10.1191/1352458503ms924oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

Review 1.  Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.

Authors:  Siming Shen; Patrizia Casaccia-Bonnefil
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

Review 2.  Aging of signal transduction pathways, and pathology.

Authors:  Morgan E Carlson; Haroldo S Silva; Irina M Conboy
Journal:  Exp Cell Res       Date:  2008-04-07       Impact factor: 3.905

3.  Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis.

Authors:  Farzin Forooghian; Roy K Cheung; W Clay Smith; Paul O'Connor; Hans-Michael Dosch
Journal:  J Clin Immunol       Date:  2007-04-10       Impact factor: 8.317

Review 4.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

Review 5.  Morphogens and blood-brain barrier function in health and disease.

Authors:  Nienke R Wevers; Helga E de Vries
Journal:  Tissue Barriers       Date:  2015-09-11

6.  Niaspan treatment improves neurological functional recovery in experimental autoimmune encephalomyelitis mice.

Authors:  Jing Zhang; Jieli Chen; Yi Li; Xu Cui; Xuguang Zheng; Cynthia Roberts; Mei Lu; Stanton B Elias; Michael Chopp
Journal:  Neurobiol Dis       Date:  2008-07-29       Impact factor: 5.996

7.  Relationship between Sonic hedgehog protein, brain-derived neurotrophic factor and oxidative stress in autism spectrum disorders.

Authors:  Laila Y Al-Ayadhi
Journal:  Neurochem Res       Date:  2011-10-09       Impact factor: 3.996

8.  Interleukin-1β induces blood-brain barrier disruption by downregulating Sonic hedgehog in astrocytes.

Authors:  Yue Wang; Shijie Jin; Yoshifumi Sonobe; Yi Cheng; Hiroshi Horiuchi; Bijay Parajuli; Jun Kawanokuchi; Tetsuya Mizuno; Hideyuki Takeuchi; Akio Suzumura
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  A novel proteolytic event controls Hedgehog intracellular sorting and distribution to receptive fields.

Authors:  Joseph R Daniele; Tehyen Chu; Sam Kunes
Journal:  Biol Open       Date:  2017-05-15       Impact factor: 2.422

10.  Purkinje cell maturation participates in the control of oligodendrocyte differentiation: role of sonic hedgehog and vitronectin.

Authors:  Lamia Bouslama-Oueghlani; Rosine Wehrlé; Mohamed Doulazmi; Xiao Ru Chen; Fanny Jaudon; Yolande Lemaigre-Dubreuil; Isabelle Rivals; Constantino Sotelo; Isabelle Dusart
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.